Literature DB >> 9518541

Comparison of the interaction of doxorubicin, daunorubicin, idarubicin and idarubicinol with large unilamellar vesicles. Circular dichroism study.

L Gallois1, M Fiallo, A Garnier-Suillerot.   

Abstract

Doxorubicin, daunorubicin and other anthracycline antibiotics constitute one of the most important groups of drugs used today in cancer chemotherapy. The details of the drug interactions with membranes are of particular importance in the understanding of their kinetics of passive diffusion through the membrane which is itself basic in the context of multidrug resistance (MDR) of cancer cells. Anthracyclines are amphiphilic molecules possessing dihydroxyanthraquinone ring system which is neutral under the physiological conditions. Their lipophilicity depends on the substituents. The amino sugar moiety bears the positive electrostatic charge localised at the protonated amino nitrogen. The four anthracyclines used in this study doxorubicin, daunorubicin, idarubicin and idarubicinol (an idarubicin metabolite readily formed inside the cells) have the same amino sugar moiety, daunosamine, with pKa of 8.4. Thus, all drugs studied will exhibit very similar electrostatic interactions with membranes, while the major differences in overall drug-membrane behaviour will result from their hydrophobic features. Circular dichroism (CD) spectroscopy was used to understand more precisely the conformational aspects of the drug-membrane systems. Large unilamellar vesicles (LUV) consisting of phosphatidylcholine, phosphatidic acid (PA) and cholesterol, were used. The anthracycline-LUV interactions depend on the molar ratio of phospholipids per drug. At low molar ratios drug:PA, these interactions depend also on the anthracycline lipophilicity. Thus, both doxorubicin and daunorubicin bind to membranes as monomers and their CD signal in the visible is positive. However, doxorubicin with its very low lipophilicity binds to the LUV through electrostatic interactions, with the dihydroxyanthraquinone moiety being in the aqueous phase, while daunorubicin, which is more lipophilic is unable to bind only through electrostatic interactions and actually the hydrophobic interactions are the only detected. The highly hydrophobic idarubicin, forms within the bilayer a rather complex entity involving 2-3 molecules of idarubicin associated in the right-handed conformation, one cholesterol molecule and also molecule(s) of phosphatidic acid, as this special oligomeric species is not detected in the absence of negatively-charged phospholipids. Idarubicinol differs from idarubicin with CH(13)-OH instead of C(13)=O and its interactions with LUV are distinctly different. Its CD signal in the visible becomes negative and no self associations of the molecule within the bilayer could be detected. The variation of the sign of the Cotton effect (positive to negative) may derive from the changes in the C(6a)-C(7)-O(7)-C(1') dihedral angle. It is noteworthy that C(13)-OH group, which strongly favours formation of the dimeric species in aqueous solutions when compared to idarubicin prevent association inside the LUV bilayer. At high ratios of phospholipids per drug all of them are embedded within the bilayer as monomer. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9518541     DOI: 10.1016/s0005-2736(97)00241-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  24 in total

Review 1.  Theoretical predictions of drug absorption in drug discovery and development.

Authors:  Patric Stenberg; Christel A S Bergström; Kristina Luthman; Per Artursson
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Liposomes as a model for the biological membrane: studies on daunorubicin bilayer interaction.

Authors:  Carla Matos; Carla Moutinho; Paulo Lobão
Journal:  J Membr Biol       Date:  2012-01-01       Impact factor: 1.843

Review 3.  Equipotent doses of daunorubicin and idarubicin for AML: a meta-analysis of clinical trials versus in vitro estimation.

Authors:  Sunil Adige; Rena G Lapidus; Brandon A Carter-Cooper; Alison Duffy; Ciera Patzke; Jennie Y Law; Maria R Baer; Nicholas P Ambulos; Ying Zou; Søren M Bentzen; Ashkan Emadi
Journal:  Cancer Chemother Pharmacol       Date:  2019-04-09       Impact factor: 3.333

4.  Complexation of anthracycline drugs with DNA in the presence of caffeine.

Authors:  M P Evstigneev; V V Khomich; D B Davies
Journal:  Eur Biophys J       Date:  2006-10-24       Impact factor: 1.733

5.  Liposome-Mediated Chemotherapeutic Delivery Is Synergistically Enhanced by Ternary Lipid Compositions and Cationic Lipids.

Authors:  Andrea N Trementozzi; Zachary I Imam; Morgan Mendicino; Carl C Hayden; Jeanne C Stachowiak
Journal:  Langmuir       Date:  2019-09-13       Impact factor: 3.882

6.  Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia.

Authors:  Ping Ma; Xiaowei Dong; Courtney L Swadley; Anshul Gupte; Markos Leggas; Harry C Ledebur; Russell J Mumper
Journal:  J Biomed Nanotechnol       Date:  2009-04       Impact factor: 4.099

7.  A biophysical approach to daunorubicin interaction with model membranes: relevance for the drug's biological activity.

Authors:  Ana Catarina Alves; Daniela Ribeiro; Miguel Horta; José L F C Lima; Cláudia Nunes; Salette Reis
Journal:  J R Soc Interface       Date:  2017-08       Impact factor: 4.118

8.  Orientation of anthracyclines in lipid monolayers and planar asymmetrical bilayers: a surface-enhanced resonance Raman scattering study.

Authors:  C Heywang; M Saint-Pierre Chazalet; C M Masson; J Bolard
Journal:  Biophys J       Date:  1998-11       Impact factor: 4.033

9.  Daunorubicin-Loaded DNA Origami Nanostructures Circumvent Drug-Resistance Mechanisms in a Leukemia Model.

Authors:  Patrick D Halley; Christopher R Lucas; Emily M McWilliams; Matthew J Webber; Randy A Patton; Comert Kural; David M Lucas; John C Byrd; Carlos E Castro
Journal:  Small       Date:  2015-11-19       Impact factor: 13.281

10.  On the interaction of doxorubicin with oleate ions: fluorescence spectroscopy and liquid-liquid extraction study.

Authors:  Emilie Munnier; Frédéric Tewes; Simone Cohen-Jonathan; Claude Linassier; Laurence Douziech-Eyrolles; Hervé Marchais; Martin Soucé; Katel Hervé; Pierre Dubois; Igor Chourpa
Journal:  Chem Pharm Bull (Tokyo)       Date:  2007-07       Impact factor: 1.645

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.